Medline opens at $35 per share in Nasdaq debut, above IPO price of $29

The largest IPO of the year, Medline, opening for trading about 15 minutes ago at $35 per share. That's up more than 20% from its IPO price of $29 per share. The company, which makes supplies products uh supplies and products used in labs and surgeries, sold more shares than initially planned in an upsized deal, more than $6 billion worth.Medline has been private for 58 years with most of its tenure familyowned until its buyout by a consortium of private equity firms in 2021. The IPO market cap is about 20 ...